SHROOM3 rs17319721 AG genotype increases risk of reduced kidney function and CKD.

Genetic variants in the SHROOM3 gene are among the most robustly associated markers for chronic kidney disease (CKD) risk in human populations. The rs17319721 polymorphism, located in the first intron of the gene, is a critical regulatory variant that influences kidney filtration capacity.

Clinical and Effectiveness Evidence

Large-scale genome-wide association studies (GWAS), including meta-analyses of over 130,000 individuals by the CKDGen Consortium, consistently identify the rs17319721-A allele as a risk factor for reduced estimated glomerular filtration rate (eGFR).

• Risk Profile: The AG (heterozygous) genotype carries a significantly higher risk of reduced kidney function compared to the GG genotype. Each copy of the A allele is associated with an approximately 2% decrease in eGFR and a 1.2-fold increase in the odds of developing CKD (p-value < 5 x 10⁻⁸).
• Population Consistency: This association has been replicated across diverse ethnic groups, including European, East Asian (Japanese and Chinese Han), and African American cohorts, confirming it as a global susceptibility marker.

Mechanistic Explanations

The rs17319721-A allele functions as a cis-acting expression quantitative trait locus (eQTL).

• Transcriptional Regulation: The A allele is located within an enhancer region and increases the binding affinity for the transcription factor TCF7L2. This leads to the overexpression of SHROOM3 in renal tubular epithelial cells and podocytes.
• Fibrotic Pathways: Overexpression of SHROOM3 activates pro-fibrotic signaling, specifically the transforming growth factor-beta (TGF-β)/Smad3 and Wnt/β-catenin pathways. This induces epithelial-to-mesenchymal transition (EMT) and increases extracellular matrix (collagen) production.
• Structural Damage: In podocytes, excessive SHROOM3 disrupts F-actin cytoskeleton organization, leading to foot process effacement and impairment of the glomerular filtration barrier.

Bottom line

The SHROOM3 rs17319721 AG genotype is a scientifically supported risk factor for reduced kidney function and increased CKD susceptibility. The A allele drives SHROOM3 overexpression, which promotes renal fibrosis and podocyte dysfunction, leading to a measurable decline in filtration capacity.